Precision AQ

Patients today expect more—personalized care, clear communication, and real-world results. Pharma is evolving to meet these demands with data-driven insights, value-based care, and a focus on equity. In his latest article in PharmaLive, Dominic Galante dives into how these changes are reshaping healthcare—and why trust is the new competitive edge. #HealthcareInnovation #PatientCenteredCare #TrustInHealthcare

AI is reshaping pharma marketing; From personalized campaigns to AI agents simplifying patient care—think managing appointments, refills, and navigation—the future of healthcare is smarter, faster, and more connected. Our EVP, Ashwin Athri, talked with Marketing & Pharma to share his vision of how these advancements will revolutionize the industry, keeping patients at the center of it all. #AIInPharma #AIInnovation #HealthcareTechnology #FurtureofHealthcare

Happy New Year! We hope you enjoyed a joyful and relaxing break. As we step into 2025 with renewed energy, our Omnichannel Solutions team invites you to revisit some highlights from 2024 with their most-popular content… 📊Searching for the “ultimate” KPI for HCP #CustomerExperience in biopharma? Read our evidence-based examination of the most relevant and actionable KPIs: https://lnkd.in/eH4D5u9V 🚀Explore the critical role of #MedicalAffairs in omnichannel product launches in our recorded webinar: https://lnkd.in/edm__3rf 🌍When it comes to #OmnichannelTransformation in biopharma, where's the industry at? Download your free report: https://lnkd.in/eyiseBew 📈Struggling to measure ROI for #OmnichannelEngagement? Read our blog on the importance of a holistic KPI framework for demonstrating business impact: https://lnkd.in/ebuPytJ4 🤖Biopharma overwhelmingly believes AI will add value to customer engagement but can’t agree where. Find out more at: https://lnkd.in/enxRBKat #PharmaIndustry #OmnichannelCustomerEngagement #Insights #Benchmarking #DigitalMaturity #OmnichannelLaunchExcellence #Healthcare #LifeSciences

Cell and gene therapies are transforming medicine—but with price tags up to $4.25M, how do we ensure access and affordability? Molly Borchardt, Erin Lopata and Philip Cyr share how innovative payment models can balance cost, risk, and access to these groundbreaking therapies in CGTLive. #CellAndGeneTherapy #ValueBasedCare #HealthcareInnovation #ReimbursementModels

Precision AQ's Investor Relations and External Communications team will be in San Francisco during J.P. Morgan Healthcare Conference week, January 13-16. Our experts are here to help biotech companies engage with the financial community and achieve their goals. Interested in meeting? Let's discuss how we can support your journey: https://lnkd.in/ewPKpaYw

Meet Laura Panattoni, PhD, a health economist whose expertise fuels access to transformative therapies and better outcomes for patients. Career Highlights: • Health economics post-doc in New Zealand • Former researcher at Fred Hutchinson Cancer Research Center and Palo Alto Medical Foundation • Expertise in claims and EHR analyses, economic modeling, and patient preference studies • Published 35+ peer-reviewed articles in oncology, chronic, and rare diseases • Presented research at leading conferences like ASCO, ISPOR, and APHA earning multiple awards, including Best General Podium Presentation at ISPOR 2023 Laura blends data-driven insights with a patient-first perspective, advancing access to transformative therapies. Her work is a testament to the power of evidence in making healthcare innovations truly impactful. Discover how Laura and the HEOR team are shaping the future of access to healthcare innovations: https://lnkd.in/e4T3eXnm #HEOR #RealWorldEvidence #HealthEconomics

With the new year just around the corner, our teams are gearing up to attend some of the most impactful healthcare conferences of the month. Whether your focus is Market Access, HEOR, Consulting or Investor Relations- Precision has experts across the healthcare landscape ready to connect and collaborate. Check out our live events page to see the January conference lineup and find out how to meet us here: https://lnkd.in/eaqQvtNz

We're excited to announce that the Precision AQ blog is now live! Our team of experts will be sharing insights and thought leadership on key topics shaping the healthcare industry. Here's what we've been writing about recently: - Reimbursement Challenges in Oncology - The Upside-Downs of Medical Benefit Drug Reimbursement - How Competitive Cx Benchmarking Could Lead to Improved Business Outcomes - Sickle Cell Disease & Gene Therapy Model Explore these articles and more for expert insights and fresh perspectives: https://lnkd.in/ejnFDnNQ

Our teams are busy finishing the work of 2024, so we delegated the making of our seasonal message to the kids of Precision. Check out a little perspective on a big year!

Our CEO, Margaret Keegan, is featured in the December issue of Pharmaceutical Executive candidly discussing the future of clinical development, the changing commercialization sector and the manufacturing of tomorrow’s medicines. The article also highlights what is possible now with AI and how Precision is helping navigate biotechnology and pharmaceutical companies into the next era of healthcare: https://lnkd.in/eSF4Dx5C #clinical #manufacturing #research #biotechnology #pharmaceutical #drugspharmaceuticals #health #healthcare #womeninscience #science